Radiofrequency ablation for metachronous hepatic metastases from gastric cancer

Surgical Laparoscopy, Endoscopy and Percutaneous Techniques

Volumn 19, Issue 3, 2009, Pages 208-212

  Kim, Hyung Ook ^a   Hwang, Sang Il ^a   Hong, Hyun Pyo ^a   Yoo, Chang Hak ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Gastric cancer; Hepatic metastases; Radiofrequency ablation

Indexed keywords

CEFOTAXIME; CISPLATIN; DOCETAXEL; METRONIDAZOLE;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER SURGERY; CLINICAL ARTICLE; DISEASE FREE SURVIVAL; EPIGASTRIC PAIN; FEMALE; FEVER; GASTRECTOMY; HUMAN; LIVER ABSCESS; LIVER METASTASIS; LIVER RESECTION; MALE; MEDICAL RECORD REVIEW; PRIORITY JOURNAL; PROGNOSIS; RADIOFREQUENCY ABLATION; RECURRENT CANCER; RETROSPECTIVE STUDY; STOMACH ADENOCARCINOMA;

ADENOCARCINOMA; ADULT; AGED; BIOPSY, NEEDLE; CATHETER ABLATION; FEMALE; FOLLOW-UP STUDIES; GASTRECTOMY; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 68549085303     PISSN: 15304515     EISSN: 15344908     Source Type: Journal    
DOI: 10.1097/SLE.0b013e3181a033d7     Document Type: Article

References (27)

1. Geoghegan JG, Scheele J. Treatment of colorectal liver metastases. Br J Surg. 1999;86:158-169.
2. Minagawa M, Makuuchi M, Torzilli G, et al. Extension of the frontiers of surgical indications in the treatment of liver metastases from colorectal cancer: long-term results. Ann Surg. 2000;231:487-499.
3. Scheele J, Stangl R, Altendorf-Hofmann A. Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg. 1990;77:1241-1246.
4. Yamamoto J, Shimada K, Kosuge T, et al. Factors influencing survival of patients undergoing hepatectomy for colorectal metastases. Br J Surg. 1999;86:332-337.
5. Yoshimi F, Asato Y, Suzuki A, et al. Long-term survival after repeat resections of metastases in liver, lung, and stomach from sigmoid colon cancer: report of a case. Surg Today. 2007;37: 53-60.
6. Roh HR, Suh KS, Lee HJ, et al. Outcome of hepatic resection for metastatic gastric cancer. Am Surg. 2005;71:95-99.
7. Sakamoto Y, Ohyama S, Yamamoto J, et al. Surgical resection of liver metastases of gastric cancer: an analysis of a 17-year experience with 22 patients. Surgery. 2003;133:507-511.
8. Nakamura R, Saikawa Y, Kumagai K, et al. A patient with gastric cancer and liver metastases successfully treated with combination chemotherapy including S-1. Int J Clin Oncol. 2007;12:295-299.
9. Tono T, Iwazawa T, Matsui S, et al. Hepatic arterial infusion of paclitaxel for liver metastasis from gastric cancer. Cancer Invest. 2004;22:550-554.
10. Taniguchi H, Takahashi T, Sawai K, et al. Comparison in survival between hepatic metastases of gastric and colorectal cancers. Hepatogastroenterology. 1997;44:897-900.
11. Yamakado K, Nakatsuka A, Takaki H, et al. Prospective study of arterial infusion chemotherapy followed by radio-frequency ablation for the treatment of liver metastasis of gastric cancer. J Vasc Interv Radiol. 2005;16:1747-1751.
12. Okano K, Maeba T, Ishimura K, et al. Hepatic resection for metastatic tumors from gastric cancer. Ann Surg. 2002;235: 86-91.
13. Imamura H, Matsuyama Y, Shimada R, et al. A study of factors influencing prognosis after resection of hepatic metastases from colorectal and gastric carcinoma. Am J Gastroenterol. 2001;96:3178-3184.
14. Koga R, Yamamoto J, Ohyama S, et al. Liver resection for metastatic gastric cancer: experience with 42 patients including eight long-term survivors. Jpn J Clin Oncol. 2007; 37:836-842.
15. Ambiru S, Miyazaki M, Ito H, et al. Benefits and limits of hepatic resection for gastric metastases. Am J Surg. 2001; 181:279-283.
16. Di Bartolomeo M, Buzzoni R, Mariani L, et al. Feasibility of sequential therapy with FOLFIRI followed by docetaxel/ cisplatin in patients with radically resected gastric adeno-carcinoma. A randomized phase III trial. Oncology. 2006;71: 341-346.
17. Koizumi W, Narahara H, Hara T, et al. S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial. Lancet Oncol. 2008.
18. Ojima H, Ootake S, Yokobori T, et al. Treatment of multiple liver metastasis from gastric carcinoma. World J Surg Oncol. 2007;5:70.
19. Rafique M, Adachi W, Kajikawa S, et al. Management of gastric cancer patients with synchronous hepatic metastasis: a retrospective study. Hepatogastroenterology. 1995;42:666-671.
20. Moriya A, Hyodo I, Nishina T, et al. Extensive liver metastasis of gastric cancer effectively treated by hepatic arterial infusion of 5-fluorouracil/cisplatin. Gastric Cancer. 2000;3:110-115.
21. Siperstein AE, Berber E, Ballem N, et al. Survival after radiofrequency ablation of colorectal liver metastases: 10-year experience. Ann Surg. 2007;246:559-565; discussion 65-67.
22. Chen MH, Yang W, Yan K, et al. Treatment efficacy of radiofrequency ablation of 338 patients with hepatic malignant tumor and the relevant complications. World J Gastroenterol. 2005;11:6395-6401.
23. Oshowo A, Gillams A, Harrison E, et al. Comparison of resection and radiofrequency ablation for treatment of solitary colorectal liver metastases. Br J Surg. 2003;90:1240-1243.
24. Livraghi T, Solbiati L, Meloni F, et al. Percutaneous radio-frequency ablation of liver metastases in potential candidates for resection: the "test-of-time approach". Cancer. 2003;97: 3027-3035.
25. Park IJ, Kim HC, Yu CS, et al. Radiofrequency ablation for metachronous liver metastasis from colorectal cancer after curative surgery. Ann Surg Oncol. 2008;15:227-232.
26. Ahmad A, Chen SL, Kavanagh MA, et al. Radiofrequency ablation of hepatic metastases from colorectal cancer: are newer generation probes better? Am Surg. 2006;72:875-879.
27. Berber E, Ari E, Herceg N, et al. Laparoscopic radiofrequency thermal ablation for unusual hepatic tumors: operative indications and outcomes. Surg Endosc. 2005;19:1613-1617.